EU drug regulator EMA records 415 cases of possible rare blood clotting
The EU drug regulator said on Thursday it has received reports of 415 possible cases of rare blood clotting with a low platelet count in the European Economic Area, out of more than 50 million people who have received AstraZeneca and Johnson & Johnson COVID-19 vaccines.
There have been 10 possible cases among just under 6 million people who received J&J’s shot in the EEA, and 405 cases among 45 million who received AstraZeneca’s shot, Georgy Genov, head of pharmacovigilance at the European Medicines Agency said in a briefing.
The condition is known as thrombosis with thrombocytopenia syndrome (TTS).
Reuters


